Bel20 (BEL20.BXS)

Close: 3 761.99 (-88.33), Feb 26, 2021
Positive

Medium risk

Automatic technical analysis. Medium term, Feb 26, 2021

Bel20 shows strong development within a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The price has reacted back after a possible false break of rectangle formation. A decisive break up through 3782 will again give new positive signals to the index, while a break on the opposite side of the formation will be a strong negative signal. The index is approacing resistance at 3880 points, which may give a negative reaction. However, a break upwards through 3880 points will be a positive signal. The RSI curve shows a rising trend, which supports the positive trend. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 65)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.14%0.00-2.29%
5 days0.003.92%0.00-1.97%
22 days0.0011.02%0.00+3.20%
66 days0.0025.59%0.00+1.01%

More analyses of Bel20

chart Bel20 (BEL20) Candlesticks 22 Days
Candlesticks
chart Bel20 (BEL20) Short term
Short term: Positive
chart Bel20 (BEL20) Medium term
Medium term: Positive
chart Bel20 (BEL20) Long term
Long term: Weak Negative
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK